Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zhan-Guo Gao & Kenneth A Jacobson. (2011) Emerging adenosine receptor agonists – an update. Expert Opinion on Emerging Drugs 16:4, pages 597-602.
Read now
Read now
Pasquale Santangeli, Luigi Di Biase, Gemma Pelargonio, J. David Burkhardt & Andrea Natale. (2011) The pharmaceutical pipeline for atrial fibrillation. Annals of Medicine 43:1, pages 13-32.
Read now
Read now
Elfatih Elzein & Jeff Zablocki. (2008) A1 adenosine receptor agonists and their potential therapeutic applications. Expert Opinion on Investigational Drugs 17:12, pages 1901-1910.
Read now
Read now
Articles from other publishers (83)
Jolanta Natalia Latosińska, Magdalena Latosińska, Janez Seliger & Veselko Žagar. (2023) Exploring Partial Structural Disorder in Anhydrous Paraxanthine through Combined Experiment, Solid-State Computational Modelling, and Molecular Docking. Processes 11:9, pages 2740.
Crossref
Crossref
Yongxiu Huang, Anqi Zeng & Linjiang Song. (2023) Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer. Frontiers in Immunology 14.
Crossref
Crossref
Pnina Fishman, Salomon M. Stemmer, Avital Bareket-Samish, Michael H. Silverman & William D. Kerns. (2023) Targeting the A3 adenosine receptor to treat hepatocellular carcinoma: anti-cancer and hepatoprotective effects. Purinergic Signalling.
Crossref
Crossref
Ana B. Caniceiro, Beatriz Bueschbell, Anke C. Schiedel & Irina S. Moreira. (2022) Class A and C GPCR Dimers in Neurodegenerative Diseases. Current Neuropharmacology 20:11, pages 2081-2141.
Crossref
Crossref
Antony JustinMeghana BasavarajDeepthi MuruganGaddam Narasimha RaoJeyaram Bharathi J. (2022) Role of A1 Adenosinergic System in Multiple Sclerosis and Possible Therapeutic Strategy. Research Journal of Pharmacy and Technology, pages 3025-3028.
Crossref
Crossref
Shaolei Luo, Yangyang Hou, Yaping Zhang, Tengfei Ma, Wenping Shao & Chunjie Xiao. (2020) Adenosine A<sub>2A</sub> Receptor Agonist PSB-0777 Modulates Synaptic Proteins and AMPA Receptor Expression in a Dose- and Time-Dependent Manner in Rat Primary Cortical Neurons. Biological and Pharmaceutical Bulletin 43:8, pages 1159-1171.
Crossref
Crossref
Pobitra Borah, Satyendra Deka, Raghu Prasad Mailavaram & Pran Kishore Deb. (2019) P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future. Current Pharmaceutical Design 25:26, pages 2792-2807.
Crossref
Crossref
Pran Kishore Deb, Satyendra Deka, Pobitra Borah, Sara N. Abed & Karl-Norbert Klotz. (2019) Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives. Current Pharmaceutical Design 25:25, pages 2697-2715.
Crossref
Crossref
Trevor Simard, Richard Jung, Alisha Labinaz, Mohammad Ali Faraz, F. Daniel Ramirez, Pietro Di Santo, Ian Pitcher, Pouya Motazedian, Chantal Gaudet, Rebecca Rochman, Jeffrey Marbach, Paul Boland, Kiran Sarathy, Saleh Alghofaili, Juan J. Russo, Etienne Couture, Rob S. Beanlands & Benjamin Hibbert. (2019) Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective. Cardiovascular & Hematological Disorders-Drug Targets 19:2, pages 109-131.
Crossref
Crossref
C.F. Burgos, C. Sanchéz, C. Sepúlveda, E. Fuentes, I. Palomo & M. Alarcón. (2019) Anti-aggregation effect on platelets of Indiplon a hypnotic sedative non-benzodiazepine drug. Biomedicine & Pharmacotherapy 111, pages 378-385.
Crossref
Crossref
Cho Hee Bang, Cholhee Kim, Jae-Hoon Kim, Sung Jae Choi, Gwan Gyu Song & Jae Hyun Jung. (2018) Is knee osteoarthritis related to coffee drinking? A nationwide cross-sectional observational study. Clinical Rheumatology 38:3, pages 817-825.
Crossref
Crossref
Eisuke Horigome, Michiru Fujieda, Tadashi Handa, Ayaka Katayama, Masashi Ito, Ami Ichihara, Daiki Tanaka, Navchaa Gombodorj, Shinji Yoshiyama, Arito Yamane, Keiichi Yamada, Jun Horiguchi, Kazuo Shinozuka, Tetsunari Oyama, Masahiko Nishiyama & Susumu Rokudai. (2018) Mutant TP53 modulates metastasis of triple negative breast cancer through adenosine A2b receptor signaling. Oncotarget 9:77, pages 34554-34566.
Crossref
Crossref
Zhan-Guo Gao, Dilip K. Tosh, Shanu Jain, Jinha Yu, Rama R. Suresh & Kenneth A. Jacobson. 2018. The Adenosine Receptors. The Adenosine Receptors
59
89
.
Daniela Salvemini, Timothy M. Doyle, Tally M. Largent-Milnes & Todd W. Vanderah. 2018. The Adenosine Receptors. The Adenosine Receptors
413
437
.
Dong Guo, Laura H. Heitman & Adriaan P. IJzerman. (2016) Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors. Chemical Reviews 117:1, pages 38-66.
Crossref
Crossref
Katia Varani, Fabrizio Vincenzi, Stefania Merighi, Stefania Gessi & Pier Andrea Borea. 2017. Protein Reviews. Protein Reviews
193
232
.
K Janes, AM Symons-Liguori, K A Jacobson & D Salvemini. (2016)
Identification of A
3
adenosine receptor agonists as novel non-narcotic analgesics
. British Journal of Pharmacology 173:8, pages 1253-1267.
Crossref
Crossref
Dong Guo, Gabrielle S. Dijksteel, Tirsa van Duijl, Maxime Heezen, Laura H. Heitman & Adriaan P. IJzerman. (2016) Equilibrium and kinetic selectivity profiling on the human adenosine receptors. Biochemical Pharmacology 105, pages 34-41.
Crossref
Crossref
Liane Saíz-Urra, Marta Teijeira, Virginia Rivero-Buceta, Aliuska Morales Helguera, Maria Celeiro, Mª Carmen Terán, Pedro Besada & Fernanda Borges. (2015) Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human $$\mathbf{A}_{3}$$ A 3 adenosine receptor ligands. Molecular Diversity 20:1, pages 55-76.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
82
84
.
Hiroki Kasama, Yosuke Sakamoto, Atsushi Kasamatsu, Atsushi Okamoto, Tomoyoshi Koyama, Yasuyuki Minakawa, Katsunori Ogawara, Hidetaka Yokoe, Masashi Shiiba, Hideki Tanzawa & Katsuhiro Uzawa. (2015) Adenosine A2b receptor promotes progression of human oral cancer. BMC Cancer 15:1.
Crossref
Crossref
Romeo Romagnoli, Pier Giovanni Baraldi, Allan R Moorman, Pier Andrea Borea & Katia Varani. (2015)
Current status of A
1
adenosine receptor allosteric enhancers
. Future Medicinal Chemistry 7:10, pages 1247-1259.
Crossref
Crossref
Dong Guo, Adriaan P. IJzerman & Laura H. Heitman. 2015. Thermodynamics and Kinetics of Drug Binding. Thermodynamics and Kinetics of Drug Binding
257
272
.
Delia Preti, Pier Giovanni Baraldi, Giulia Saponaro, Romeo Romagnoli, Mojgan Aghazadeh Tabrizi, Stefania Baraldi, Sandro Cosconati, Agostino Bruno, Ettore Novellino, Fabrizio Vincenzi, Annalisa Ravani, Pier Andrea Borea & Katia Varani. (2015)
Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5′-
N
-ethylcarboxamidoadenosines as Potent and Selective Agonists of the A
2A
Adenosine Receptor
. Journal of Medicinal Chemistry 58:7, pages 3253-3267.
Crossref
Crossref
Tianhua Ren, Ting Tian, Xiao Feng, Shicai Ye, Hao Wang, Weiyun Wu, Yumei Qiu, Caiyuan Yu, Yanting He, Juncheng Zeng, Junwei Cen & Yu Zhou. (2015) An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway. Scientific Reports 5:1.
Crossref
Crossref
Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Stefania Merighi & Stefania Gessi. (2015)
The A
3
Adenosine Receptor: History and Perspectives
. Pharmacological Reviews 67:1, pages 74-102.
Crossref
Crossref
Dong Guo, Suzanne N Venhorst, Arnault Massink, Jacobus P D van Veldhoven, Georges Vauquelin, Adriaan P IJzerman & Laura H Heitman. (2014)
Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A
1
adenosine receptor
. British Journal of Pharmacology 171:23, pages 5295-5312.
Crossref
Crossref
Karen Nieber & Sebastian Michael. (2014) Adenosine receptors: Intermembrane receptor–receptor interactions in the brain. Synergy 1:2, pages 83-91.
Crossref
Crossref
Raymond Wong & Lyanne C. Schlichter. (2014)
PKA Reduces the Rat and Human KCa3.1 Current, CaM Binding, and Ca
2+
Signaling, Which Requires Ser332/334 in the CaM-Binding C Terminus
. The Journal of Neuroscience 34:40, pages 13371-13383.
Crossref
Crossref
Romeo Romagnoli, Pier Giovanni Baraldi, Adriaan P. IJzerman, Arnault Massink, Olga Cruz-Lopez, Luisa Carlota Lopez-Cara, Giulia Saponaro, Delia Preti, Mojgan Aghazadeh Tabrizi, Stefania Baraldi, Allan R. Moorman, Fabrizio Vincenzi, Pier Andrea Borea & Katia Varani. (2014)
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A
1
Adenosine Receptor Based on 2-Amino-3-(4′-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene
. Journal of Medicinal Chemistry 57:18, pages 7673-7686.
Crossref
Crossref
Md. Kaimul Ahsan & Wajahat Z. Mehal. (2014) Activation of adenosine receptor A2A increases HSC proliferation and inhibits death and senescence by down-regulation of p53 and Rb. Frontiers in Pharmacology 5.
Crossref
Crossref
Constantin I. Tănase, Constantin Drăghici, Miron Teodor Căproiu, Sergiu Shova, Christophe Mathe, Florea G. Cocu, Cristian Enache & Maria Maganu. (2014) New carbocyclic nucleoside analogues with a bicyclo[2.2.1]heptane fragment as sugar moiety; Synthesis, X-ray crystallography and anticancer activity. Bioorganic & Medicinal Chemistry 22:1, pages 513-522.
Crossref
Crossref
Isis Bonet, Pedro Franco-Montero, Virginia Rivero, Marta Teijeira, Fernanda Borges, Eugenio Uriarte & Aliuska Morales Helguera. (2013)
Classifier Ensemble Based on Feature Selection and Diversity Measures for Predicting the Affinity of A
2B
Adenosine Receptor Antagonists
. Journal of Chemical Information and Modeling 53:12, pages 3140-3155.
Crossref
Crossref
Diego Dal Ben, Michela Buccioni, Catia Lambertucci, Ajiroghene Thomas & Rosaria Volpini. (2013) Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor. In Silico Pharmacology 1:1.
Crossref
Crossref
Yu Zhu, Liangming Liu, Xiaoyong Peng, Xiaoli Ding, Guangming Yang & Tao Li. (2013) Role of adenosine A2A receptor in organ-specific vascular reactivity following hemorrhagic shock in rats. Journal of Surgical Research 184:2, pages 951-958.
Crossref
Crossref
Romeo Romagnoli, Pier Giovanni Baraldi, Maria Dora Carrion, Carlota Lopez Cara, Maria Kimatrai Salvador, Delia Preti, Mojgan Aghazadeh Tabrizi, Allan R. Moorman, Fabrizio Vincenzi, Pier Andrea Borea & Katia Varani. (2013) Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor. European Journal of Medicinal Chemistry 67, pages 409-427.
Crossref
Crossref
Dong Guo, Erika J.H. van Dorp, Thea Mulder-Krieger, Jacobus P.D. van Veldhoven, Johannes Brussee, Adriaan P. IJzerman & Laura H. Heitman. (2013) Dual-Point Competition Association Assay: A Fast and High-Throughput Kinetic Screening Method for Assessing Ligand-Receptor Binding Kinetics. SLAS Discovery 18:3, pages 309-320.
Crossref
Crossref
Fatemeh Kermanian, Mansooreh Soleimani, Alireza Ebrahimzadeh, Hossein Haghir & Mehdi Mehdizadeh. (2012) Effects of adenosine A2a receptor agonist and antagonist on hippocampal nuclear factor-kB expression preceded by MDMA toxicity. Metabolic Brain Disease 28:1, pages 45-52.
Crossref
Crossref
B. Donatini. (2013) L’Armillaire miel: un agoniste adénosine A1 actif contre les vertiges et un agent potentiel contre les effets délétères de l’ischémieArmillaria mellea: an adenosine A1 agonist useful against dizziness and a possible anti-ischemic agent. Phytothérapie 11:1, pages 39-41.
Crossref
Crossref
Fabrizio Vincenzi, Melissa Padovan, Martina Targa, Carmen Corciulo, Sarah Giacuzzo, Stefania Merighi, Stefania Gessi, Marcello Govoni, Pier Andrea Borea & Katia Varani. (2013) A2A Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats. PLoS ONE 8:1, pages e54195.
Crossref
Crossref
Chen Ning, Lin Qi, Jiaming Wen, Yujin Zhang, Weiru Zhang, Wei Wang, Michael Blackburn, Rodney Kellems & Yang Xia. (2012) Excessive Penile Norepinephrine Level Underlies Impaired Erectile Function in Adenosine A1 Receptor Deficient Mice. The Journal of Sexual Medicine 9:10, pages 2552-2561.
Crossref
Crossref
Sunil K. Panchal, Weng-Yew Wong, Kate Kauter, Leigh C. Ward & Lindsay Brown. (2012) Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition 28:10, pages 1055-1062.
Crossref
Crossref
Ilia Korboukh, Emily A. Hull-Ryde, Joseph E. Rittiner, Amarjit S. Randhawa, Jennifer Coleman, Brendan J. Fitzpatrick, Vincent Setola, William P. Janzen, Stephen V. Frye, Mark J. Zylka & Jian Jin. (2012)
Orally Active Adenosine A
1
Receptor Agonists with Antinociceptive Effects in Mice
. Journal of Medicinal Chemistry 55:14, pages 6467-6477.
Crossref
Crossref
Dong Guo, Thea Mulder-Krieger, Adriaan P IJzerman & Laura H Heitman. (2012) Functional efficacy of adenosine A2A receptor agonists is positively correlated to their receptor residence time. British Journal of Pharmacology 166:6, pages 1846-1859.
Crossref
Crossref
Geoffrey Burnstock & Alexei VerkhratskyGeoffrey Burnstock & Alexei Verkhratsky. 2012. Purinergic Signalling and the Nervous System. Purinergic Signalling and the Nervous System
7
66
.
Feng Luan, André Melo, Fernanda Borges & M. Natália D.S. Cordeiro. (2011) Affinity prediction on A3 adenosine receptor antagonists: The chemometric approach. Bioorganic & Medicinal Chemistry 19:22, pages 6853-6859.
Crossref
Crossref
Gordon L. Warren, Tracy Hulderman, Angie Liston & Petia P. Simeonova. (2011) Toll-like and adenosine receptor expression in injured skeletal muscle. Muscle & Nerve 44:1, pages 85-92.
Crossref
Crossref
F. Ru, L. Surdenikova, M. Brozmanova & M. Kollarik. (2011) Adenosine-induced activation of esophageal nociceptors. American Journal of Physiology-Gastrointestinal and Liver Physiology 300:3, pages G485-G493.
Crossref
Crossref
Michael V. CohenJames M. Downey. (2011) Ischemic Postconditioning: From Receptor to End-Effector. Antioxidants & Redox Signaling 14:5, pages 821-831.
Crossref
Crossref
Darren D O’Rielly & Proton Rahman. (2011) Pharmacogenetics of psoriasis. Pharmacogenomics 12:1, pages 87-101.
Crossref
Crossref
Michael Koeppen, Tobias Eckle & Holger K. Eltzschig. 2011. Pharmacology of Purine and Pyrimidine Receptors. Pharmacology of Purine and Pyrimidine Receptors
145
186
.
De-Fu Ma, Tetsuo Kondo, Tadao Nakazawa, Dong-Feng Niu, Kunio Mochizuki, Tomonori Kawasaki, Tetsu Yamane & Ryohei Katoh. (2010) Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells. Human Pathology 41:11, pages 1550-1557.
Crossref
Crossref
J. Robert Lane, Elisabeth Klaasse, Judy Lin, John van Bruchem, Margot W. Beukers & Adriaan P. IJzerman. (2010) Characterization of [3H]LUF5834: A novel non-ribose high-affinity agonist radioligand for the adenosine A1 receptor. Biochemical Pharmacology 80:8, pages 1180-1189.
Crossref
Crossref
Celine Valant, Luigi Aurelio, Vijay B. Urmaliya, Paul White, Peter J. Scammells, Patrick M. Sexton & Arthur Christopoulos. (2010)
Delineating the Mode of Action of Adenosine A
1
Receptor Allosteric Modulators
. Molecular Pharmacology 78:3, pages 444-455.
Crossref
Crossref
G. Burnstock, B. B. Fredholm, R. A. North & A. Verkhratsky. (2010) The birth and postnatal development of purinergic signalling. Acta Physiologica 199:2, pages 93-147.
Crossref
Crossref
David L. Clark, Nash N. Boutros & Mario F. Mendez. 2010. The Brain and Behavior. The Brain and Behavior
14
32
.
Shane M. Devine, Alison Gregg, Heidi Figler, Kate McIntosh, Vijay Urmaliya, Joel Linden, Colin W. Pouton, Paul J. White, Steven E. Bottle & Peter J. Scammells. (2010) Synthesis and evaluation of new N6-substituted adenosine-5′-N-methylcarboxamides as A3 adenosine receptor agonists. Bioorganic & Medicinal Chemistry 18:9, pages 3078-3087.
Crossref
Crossref
Michael V Cohen, Xiulan Yang & James M Downey. (2010) A2b adenosine receptors can change their spots. British Journal of Pharmacology 159:8, pages 1595-1597.
Crossref
Crossref
Neha RanaMamta MoondAmarnath MarthiSwetha BapatlaTejasudha SarvepalliKiranam ChattiAnil Kumar Challa. (2010) Caffeine-Induced Effects on Heart Rate in Zebrafish Embryos and Possible Mechanisms of Action: An Effective System for Experiments in Chemical Biology. Zebrafish 7:1, pages 69-81.
Crossref
Crossref
Francisco Ciruela, Catarina Albergaria, Aroa Soriano, Laura Cuffí, Lourdes Carbonell, Silvia Sánchez, Jorge Gandía & Víctor Fernández-Dueñas. (2010) Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling. Biochimica et Biophysica Acta (BBA) - Biomembranes 1798:1, pages 9-20.
Crossref
Crossref
Felicita Pedata, Anna Maria Pugliese, Ana M. Sebastião & Joaquim A. Ribeiro. 2010. A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics. A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics
165
188
.
Gregory D. Stewart, Celine Valant, Simon J. Dowell, Dalibor Mijaljica, Rodney J. Devenish, Peter J. Scammells, Patrick M. Sexton & Arthur Christopoulos. (2009)
Determination of Adenosine A
1
Receptor Agonist and Antagonist Pharmacology Using
Saccharomyces cerevisiae
: Implications for Ligand Screening and Functional Selectivity
. Journal of Pharmacology and Experimental Therapeutics 331:1, pages 277-286.
Crossref
Crossref
Katia Varani, Alfonso Massara, Fabrizio Vincenzi, Alice Tosi, Melissa Padovan, Francesco Trotta & Pier Andrea Borea. (2009)
Normalization of A
2A
and A
3
adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate
. Arthritis & Rheumatism 60:10, pages 2880-2891.
Crossref
Crossref
Wael Al Jaroudi & Ami E. Iskandrian. (2009) Regadenoson: A New Myocardial Stress Agent. Journal of the American College of Cardiology 54:13, pages 1123-1130.
Crossref
Crossref
Vijay Kumar & Ambika Sharma. (2009) Adenosine: An endogenous modulator of innate immune system with therapeutic potential. European Journal of Pharmacology 616:1-3, pages 7-15.
Crossref
Crossref
Gianluca Aguiari, Katia Varani, Marco Bogo, Alessandra Mangolini, Fabrizio Vincenzi, Chiara Durante, Stefania Gessi, Valeria Sacchetto, Luigi Catizone, Peter Harris, Rosario Rizzuto, Pier Andrea Borea & Laura del Senno. (2009) Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1792:6, pages 531-540.
Crossref
Crossref
María Isabel Nieto, María Carmen Balo, José Brea, Olga Caamaño, María Isabel Cadavid, Franco Fernández, Xerardo García Mera, Carmen López & José Enrique Rodríguez-Borges. (2009) Synthesis of novel 1-alkyl-8-substituted-3-(3-methoxypropyl) xanthines as putative A2B receptor antagonists. Bioorganic & Medicinal Chemistry 17:9, pages 3426-3432.
Crossref
Crossref
Palmarisa Franchetti, Loredana Cappellacci, Patrizia Vita, Riccardo Petrelli, Antonio Lavecchia, Sonja Kachler, Karl-Norbert Klotz, Ida Marabese, Livio Luongo, Sabatino Maione & Mario Grifantini. (2009)
N
6
-Cycloalkyl- and
N
6
-Bicycloalkyl-
C
5′(
C
2′)-modified Adenosine Derivatives as High-Affinity and Selective Agonists at the Human A
1
Adenosine Receptor with Antinociceptive Effects in Mice
. Journal of Medicinal Chemistry 52:8, pages 2393-2406.
Crossref
Crossref
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, Romeo Romagnoli & Delia Preti. (2009) Recent improvements in the development of A2B adenosine receptor agonists. Purinergic Signalling 5:1, pages 3-19.
Crossref
Crossref
Zhan-Guo Gao, Bao Teng, Haitao Wu, Bhalchandra V. Joshi, Gary L. Griffiths & Kenneth A. Jacobson. (2008) Synthesis and pharmacological characterization of [125I]MRS1898, a high-affinity, selective radioligand for the rat A3 adenosine receptor. Purinergic Signalling 5:1, pages 31-37.
Crossref
Crossref
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs
263
429
.
Arvinder K. Dhalla, Jeffrey W. Chisholm, Gerald M. Reaven & Luiz Belardinelli. 2009. Adenosine Receptors in Health and Disease. Adenosine Receptors in Health and Disease
271
295
.
Ana M. Sebastião & Joaquim A. Ribeiro. 2009. Adenosine Receptors in Health and Disease. Adenosine Receptors in Health and Disease
471
534
.
Constance N. Wilson, Ahmed Nadeem, Domenico Spina, Rachel Brown, Clive P. Page & S. Jamal Mustafa. 2009. Adenosine Receptors in Health and Disease. Adenosine Receptors in Health and Disease
329
362
.
Muhammad A. Sohail, Ardeshir Z. Hashmi, Wyel Hakim, Azuma Watanabe, Alexander Zipprich, Roberto J. Groszmann, Jonathan A. Dranoff, Natalie J. Torok & Wajahat Z. Mehal. (2009) Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology 49:1, pages 185-194.
Crossref
Crossref
Zhan-Guo Gao, Kai Ye, Anikó Göblyös, Adriaan P IJzerman & Kenneth A Jacobson. (2008) Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000. BMC Pharmacology 8:1.
Crossref
Crossref
Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Francesca Fruttarolo, Romeo Romagnoli & Delia Preti. (2008) Recent improvements in the development of A2B adenosine receptor agonists. Purinergic Signalling 4:4, pages 287-303.
Crossref
Crossref
B. A. Rothermel & J. A. Hill. (2008) Adenosine A3 Receptor and Cardioprotection: Enticing, Enigmatic, Elusive. Circulation 118:17, pages 1691-1693.
Crossref
Crossref
Hideyuki Migita, Katsuya Kominami, Mami Higashida, Rumi Maruyama, Nobuko Tuchida, Fiona McDonald, Fumiki Shimada & Kazuhiro Sakurada. (2008)
Activation of adenosine A
1
receptor-induced neural stem cell proliferation via MEK/ERK and Akt signaling pathways
. Journal of Neuroscience Research 86:13, pages 2820-2828.
Crossref
Crossref
Kenneth G. Proctor. (2008) Hypertonic resuscitation: Is it all in the timing?*. Critical Care Medicine 36:9, pages 2692-2693.
Crossref
Crossref
Andrei A. Ivanov, Ben Wang, Athena M. Klutz, Vincent L. Chen, Zhan-Guo Gao & Kenneth A. Jacobson. (2008)
Probing Distal Regions of the A
2B
Adenosine Receptor by Quantitative Structure−Activity Relationship Modeling of Known and Novel Agonists
. Journal of Medicinal Chemistry 51:7, pages 2088-2099.
Crossref
Crossref
György Haskó & Pál Pacher. (2008) A2A receptors in inflammation and injury: lessons learned from transgenic animals. Journal of Leukocyte Biology 83:3, pages 447-455.
Crossref
Crossref
J.K. Aronson. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
209
222
.